title: Evidence for CRK3 participation in the cell division cycle of Trypanosoma cruzi.
abstract: Trypanosoma cruzi CRK3 gene encodes a Cdc2p related protein kinase (CRK). To establish if it has a role in the regulation of the parasite cell cycle we studied CRK3 expression and activity throughout three life cycle stages. CRK3 from epimastigote soluble extracts interacted with p13(suc1)-beads. Endogenous CRK3 phosphorylated histone H1 and this activity was inhibited by specific CDK inhibitors: Olomoucine, Flavopiridol and Roscovitine. Flavopiridol partially inhibited the growth of T. cruzi epimastigotes at 50 nM, the lowest concentration used, but even with the highest (5 microM), cell growth was not completely arrested. CRK3 from Flavopiridol-inhibited epimastigote extracts exhibited a dose dependent inhibition of histone H1 phosphorylation. T. cruzi p13(suc1)-binding CRK displayed the same inhibition profile. This suggests that CRK3 is the enzyme responsible for the majority of the kinase activity associated with p13(suc1). CRK3 activity of hydroxyurea (HU) synchronized epimastigotes peaked in G2/M boundary while the kinase activity associated to p13(suc1)-beads increased at the same time point but remained high until late G2/M. In addition, CRK3 expression was constant during the cell cycle. This is a common pattern of CDK activity regulation. Taken together, these results support the idea that CRK3 is involved in control of the cell cycle in T. cruzi.
authors.affiliation: Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (IGEBI, CONICET) and Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Vuelta de Obligado 2490 (1428), Buenos Aires, Argentina.
authors.forename: María I
authors.initials: MI
authors.lastname: Santori
authors.forename: Sebastián
authors.initials: S
authors.lastname: Laría
authors.forename: Eliana B
authors.initials: EB
authors.lastname: Gómez
authors.forename: Ingrid
authors.initials: I
authors.lastname: Espinosa
authors.forename: Norbel
authors.initials: N
authors.lastname: Galanti
authors.forename: María T
authors.initials: MT
authors.lastname: Téllez-Iñón
mesh_terms: D000818:Animals; D016203:CDC2 Protein Kinase; D002453:Cell Cycle / Q000187:drug effects* / Q000502:physiology; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005419:Flavonoids / Q000494:pharmacology; D005786:Gene Expression Regulation; D006918:Hydroxyurea / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D015800:Protozoan Proteins; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000201:enzymology / Q000235:genetics / Q000502:physiology*
chemical_list: D004791:Enzyme Inhibitors; D005419:Flavonoids; D010880:Piperidines; D015800:Protozoan Proteins; C077990:alvocidib; D016203:CDC2 Protein Kinase; D018844:Cyclin-Dependent Kinases; D006918:Hydroxyurea